(Reuters) – Moderna Inc said on Wednesday it was in talks with the U.S. government to sell an additional 100 million doses of its COVID-19 vaccine that will be delivered in the third quarter of 2021.
(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
